Buse Baran

This study uses CRISPR/Cas12a to target and cleave Wheat Dwarf Virus genomes without genetic modification, showing effective antiviral activity in vitro.

This study creates an in vitro model of Wu Syndrome using genetic modification in neural cell lines to characterize new GRIA3 variants and their functional effects.

This paper introduces CRISPR.BOT, a robotic system for automated genetic engineering tasks, achieving high-purity single-cell subcloning and reducing labor and costs in biosafety level 3 experiments.